These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 3259258

  • 1. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice.
    Santoro TJ, Portanova JP, Kotzin BL.
    J Exp Med; 1988 May 01; 167(5):1713-8. PubMed ID: 3259258
    [Abstract] [Full Text] [Related]

  • 2. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM, Yeh ET, Sy MS.
    J Immunol; 1987 Aug 01; 139(3):734-42. PubMed ID: 3110283
    [Abstract] [Full Text] [Related]

  • 3. Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration.
    Nagata N, Nakagawa T, Hosaka N, Ikehara S.
    Immunobiology; 1992 Nov 01; 186(5):339-50. PubMed ID: 1286875
    [Abstract] [Full Text] [Related]

  • 4. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
    Davignon JL, Kimoto M, Kindler V, De Kossodo S, Vassalli P, Izui S.
    Eur J Immunol; 1988 Sep 01; 18(9):1367-72. PubMed ID: 3139430
    [Abstract] [Full Text] [Related]

  • 5. The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation.
    Katagiri T, Cohen PL, Eisenberg RA.
    J Exp Med; 1988 Mar 01; 167(3):741-51. PubMed ID: 3258351
    [Abstract] [Full Text] [Related]

  • 6. The role of L3T4+ cells in the pathogenesis of lupus in lpr-bearing mice. I. Defects in the production of interleukins 2 and 3.
    Santoro TJ, Lehmann KR, Batt RA, Kotzin BL.
    Eur J Immunol; 1987 Aug 01; 17(8):1131-6. PubMed ID: 3113978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T cell lineages in the thymus of lpr/lpr mice. Evidence for parallel pathways of normal and abnormal T cell development.
    Budd RC, Schreyer M, Miescher GC, MacDonald HR.
    J Immunol; 1987 Oct 01; 139(7):2200-10. PubMed ID: 3498754
    [Abstract] [Full Text] [Related]

  • 9. Ontogeny and function of B220+ L3T4+ T-cell subset of MRL/Mp-lpr/lpr mice.
    Kariyone A, Takiguchi M, Igarashi S, Kano K.
    Cell Immunol; 1988 Aug 01; 115(1):112-20. PubMed ID: 2456858
    [Abstract] [Full Text] [Related]

  • 10. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR, Channavajhala PL, Kiefer HL, Carmack AJ, Landesman-Bollag E, Beaudette BC, Jersky B, Salant DJ, Ju ST, Marshak-Rothstein A, Seldin DC.
    J Immunol; 1998 Nov 15; 161(10):5164-70. PubMed ID: 9820486
    [Abstract] [Full Text] [Related]

  • 11. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y, Ramnath VR, Eaton AS, Chen A, Simon-Stoos KL, Kleiner DE, Erikson J, Puck JM.
    Clin Immunol; 1999 Oct 15; 93(1):34-45. PubMed ID: 10497009
    [Abstract] [Full Text] [Related]

  • 12. Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo.
    Mountz JD, Gause WC, Finkelman FD, Steinberg AD.
    J Immunol; 1988 May 01; 140(9):2943-9. PubMed ID: 2834447
    [Abstract] [Full Text] [Related]

  • 13. Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation.
    Carlsten H, Tarkowski A.
    Scand J Immunol; 1989 Oct 01; 30(4):457-62. PubMed ID: 2814366
    [Abstract] [Full Text] [Related]

  • 14. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
    Mountz JD, Smith HR, Wilder RL, Reeves JP, Steinberg AD.
    J Immunol; 1987 Jan 01; 138(1):157-63. PubMed ID: 3537128
    [Abstract] [Full Text] [Related]

  • 15. Molecular basis of elevated c-myb expression in the abnormal L3T4-, Lyt-2- T lymphocytes of autoimmune mice.
    Evans JL, Boyle WJ, Ting JP.
    J Immunol; 1987 Nov 15; 139(10):3497-505. PubMed ID: 3316384
    [Abstract] [Full Text] [Related]

  • 16. Effect of xid on autoimmune C3H-gld/gld mice.
    Seldin MF, Reeves JP, Scribner CL, Roths JB, Davidson WF, Morse HC, Steinberg AD.
    Cell Immunol; 1987 Jun 15; 107(1):249-55. PubMed ID: 3555848
    [Abstract] [Full Text] [Related]

  • 17. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice.
    Roths JB, Murphy ED, Eicher EM.
    J Exp Med; 1984 Jan 01; 159(1):1-20. PubMed ID: 6693832
    [Abstract] [Full Text] [Related]

  • 18. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK, Fujihashi K, Taguchi T, McGhee JR, Yamamoto M, Eldridge JH, Gay S, Kiyono H.
    Eur J Immunol; 1992 Jan 01; 22(1):137-45. PubMed ID: 1346108
    [Abstract] [Full Text] [Related]

  • 19. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.
    Kanai Y, Takeda O, Miura K, Amagai M, Kaneko T, Kubota T, Kanai Y, Tanuma S, Kurosawa Y.
    Immunol Lett; 1995 Feb 01; 45(1-2):35-42. PubMed ID: 7622185
    [Abstract] [Full Text] [Related]

  • 20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.